The silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/β-Catenin pathway

Overview of attention for article published in OncoTargets and therapy, January 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 67 Dimensions

Readers on

mendeley: 29 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 67 publications that cite this research output.

67

The most recent citing publications are shown below. View all 67 publications that cite this research output on Dimensions.

Role of LncRNA H19 in tumor progression and treatment

Article in Molecular and Cellular Probes (April 2024)

RNA-Binding Motif Protein RBM47 Promotes Invasiveness of Glioblastoma Through Activation of Epithelial-to-Mesenchymal Transition Program

Article in Genetic Testing and Molecular Biomarkers (December 2023)

Immunological processes of enhancers and suppressors of long non-coding RNAs associated with brain tumors and inflammation

Article in International Reviews of Immunology (November 2023)